Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Prostate Cancer

Free Subscription 04.02.2019 1 Am J Pathol 4 BJU Int 1 BMC Cancer 4 Br J Cancer 1 Cancer 1 Clin Imaging 4 Eur Urol 1 J Cell Physiol 1 J Magn Reson Imaging 4 J Nucl Med 4 J Urol 1 Nat Rev Urol 2 PLoS One 1 Prog Urol 2 Prostate

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Pathol

1. BAUMANN B, Acosta AM, Richards Z, Deaton R, et al
   High miR-182 Levels Associate with Low-Risk Prostate Cancer.
   Am J Pathol. 2019 Jan 28. pii: S0002-9440(18)30384.
   PubMed     Text format     Abstract available
   
   

   
   BJU Int

2. SIMOPOULOS DN, Sisk AE Jr, Priester A, Felker ER, et al
   Cancer Core Length from Targeted Biopsy: An Index of Prostate Cancer Volume and Pathologic Stage.
   BJU Int. 2019 Jan 29. doi: 10.1111/bju.14691.
   PubMed     Text format     Abstract available
   
   
3. REYNOLDS BR, Bulsara C, Zeps N, Codde J, et al
   Exploring pathways towards improving patient experience of robot-assisted radical prostatectomy (RARP): assessing patient satisfaction and attitudes.
   BJU Int. 2018;121 Suppl 3:33-39.
   PubMed     Text format     Abstract available
   
   
4. ANING JJ, Reilly GS, Fowler S, Challacombe B, et al
   Peri-operative and oncological outcomes of radical prostatectomy for high-risk prostate cancer in the UK: an analysis of surgeon reported data.
   BJU Int. 2019 Jan 25. doi: 10.1111/bju.14687.
   PubMed     Text format     Abstract available
   
   
5. DE NUNZIO C, Lombardo R, Nacchia A, Tema G, et al
   Repeat prostate-specific antigen (PSA) test before prostate biopsy: a 20% decrease in PSA values is associated with a reduced risk of cancer and particularly of high-grade cancer.
   BJU Int. 2018;122:83-88.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

6. GREGOIRE C, Nicolas H, Bragard I, Delevallez F, et al
   Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients.
   BMC Cancer. 2018;18:677.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

7. NOSSITER J, Sujenthiran A, Charman SC, Cathcart PJ, et al
   Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England.
   Br J Cancer. 2018;118:489-494.
   PubMed     Text format     Abstract available
   
   
8. GREGG JR, Zheng J, Lopez DS, Reichard C, et al
   Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance.
   Br J Cancer. 2019 Jan 25. pii: 10.1038/s41416-019-0380.
   PubMed     Text format     Abstract available
   
   
9. GANJU A, Chauhan SC, Hafeez BB, Doxtater K, et al
   Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.
   Br J Cancer. 2018;118:587-599.
   PubMed     Text format     Abstract available
   
   
10. MCCLURG UL, Nabbi A, Ricordel C, Korolchuk S, et al
    Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein.
    Br J Cancer. 2018;118:713-726.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

11. GORDON BE, Basak R, Carpenter WR, Usinger D, et al
    Factors influencing prostate cancer treatment decisions for African American and white men.
    Cancer. 2019 Jan 29. doi: 10.1002/cncr.31932.
    PubMed     Text format     Abstract available
    
    

    
    Clin Imaging

12. SHEN L, Zhou G, Tang F, Lin Y, et al
    MR diffusion kurtosis imaging for cancer diagnosis: A meta-analysis of the diagnostic accuracy of quantitative kurtosis value and diffusion coefficient.
    Clin Imaging. 2018;52:44-56.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol

13. FRYDENBERG M, Woo HH
    Early Androgen Deprivation Therapy Improves Survival, But How Do We Determine in Whom?
    Eur Urol. 2018;73:519-520.
    PubMed     Text format    
    
    
14. BRAND D, Parker C
    Management of Men with Prostate-specific Antigen Failure After Prostate Radiotherapy: The Case Against Early Androgen Deprivation.
    Eur Urol. 2018;73:521-523.
    PubMed     Text format     Abstract available
    
    
15. MAHAL BA, Alshalalfa M, Spratt DE, Davicioni E, et al
    Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores.
    Eur Urol. 2019 Jan 22. pii: S0302-2838(19)30011.
    PubMed     Text format    
    
    
16. HOULAHAN KE, Salmasi A, Sadun TY, Pooli A, et al
    Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.
    Eur Urol. 2019 Jan 24. pii: S0302-2838(18)31044.
    PubMed     Text format     Abstract available
    
    

    
    J Cell Physiol

17. LI L, Du Z, Gao Y, Tang Y, et al
    PLCepsilon knockdown overcomes drug resistance to androgen receptor antagonist in castration-resistant prostate cancer by suppressing the wnt3a/beta-catenin pathway.
    J Cell Physiol. 2019 Jan 26. doi: 10.1002/jcp.28195.
    PubMed     Text format     Abstract available
    
    

    
    J Magn Reson Imaging

18. WU M, Krishna S, Thornhill RE, Flood TA, et al
    Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
    J Magn Reson Imaging. 2019 Jan 30. doi: 10.1002/jmri.26674.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

19. JOCHUMSEN MR, Tolbod LP, Pedersen BG, Nielsen MM, et al
    Quantitative tumor perfusion imaging with (82)Rubidium-PET/CT in prostate cancer - analytical and clinical validation.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.219188. doi: 10.2967/jnumed.118.219188.
    PubMed     Text format     Abstract available
    
    
20. BURGER IA, Muller J, Donati OF, Ferraro DA, et al
    (68)Ga-PSMA-11 PET/MR detects local recurrence occult on mpMRI in prostate cancer patients after HIFU.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.221564. doi: 10.2967/jnumed.118.221564.
    PubMed     Text format     Abstract available
    
    
21. JILG CA, Drendel V, Rischke HC, Beck TIR, et al
    Detection Rate of (18)F-choline-PET/CT and (68)Ga-PSMA-HBED-CC-PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220541. doi: 10.2967/jnumed.118.220541.
    PubMed     Text format     Abstract available
    
    
22. BARBER TW, Singh A, Kulkarni HR, Niepsch K, et al
    Clinical outcomes of (177)Lu-PSMA radioligand therapy in taxane chemotherapy pretreated and taxane chemotherapy naive patients with metastatic castration resistant prostate cancer.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.216820. doi: 10.2967/jnumed.118.216820.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

23. TRUONG M
    Editorial Comment.
    J Urol. 2018;200:113.
    PubMed     Text format    
    
    
24. CARLSSON S
    Editorial Comment.
    J Urol. 2018;200:87.
    PubMed     Text format    
    
    
25. GOLD SA, Shih JH, Rais-Bahrami S, Bloom JB, et al
    When to Biopsy the Seminal Vesicles: A Validated Multiparametric Magnetic Resonance Imaging and Target Driven Model to Detect Seminal Vesicle Invasion in Prostate Cancer.
    J Urol. 2019 Jan 23. doi: 10.1097/JU.0000000000000112.
    PubMed     Text format     Abstract available
    
    
26. GINSBURG KB, Arcot R, Qi J, Linsell SM, et al
    Confirmatory MRI With or Without Biopsy Impacts Decision-Making in Newly Diagnosed Favorable Risk Prostate Cancer.
    J Urol. 2019 Jan 25. doi: 10.1097/JU.0000000000000059.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Urol

27. STONE L
    Putting a SOCS in prostate cancer.
    Nat Rev Urol. 2019 Jan 28. pii: 10.1038/s41585-019-0151.
    PubMed     Text format    
    
    

    
    PLoS One

28. RODRIGUEZ-SANCHEZ L, Fernandez-Navarro P, Lopez-Abente G, Nunez O, et al
    Different spatial pattern of municipal prostate cancer mortality in younger men in Spain.
    PLoS One. 2019;14:e0210980.
    PubMed     Text format     Abstract available
    
    
29. GOUPY F, Supiot S, Pasquier D, Latorzeff I, et al
    Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysis.
    PLoS One. 2019;14:e0210514.
    PubMed     Text format     Abstract available
    
    

    
    Prog Urol

30. ARNOUIL N, Gelet A, Matillon X, Rouviere O, et al
    [Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year].
    Prog Urol. 2018;28:603-610.
    PubMed     Text format     Abstract available
    
    

    
    Prostate

31. BERGSTROM SH, Jaremo H, Nilsson M, Adamo HH, et al
    Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
    Prostate. 2018;78:257-265.
    PubMed     Text format     Abstract available
    
    
32. GAUR S, Gross ME, Liao CP, Qian B, et al
    Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.
    Prostate. 2019 Jan 28. doi: 10.1002/pros.23774.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: